How comparing works here
How do I compare two companies?
Type the tickers into the box above — up to five at once. Every row is read from the companies' own annual filings, so a comparison shows the same measure computed the same way for each of them rather than whatever each company chose to highlight.
Can I compare an ETF with a stock?
Yes, and the table changes to suit. Two funds are compared on cost, income, spread and record, because revenue growth and debt mean nothing for a fund. A fund against a company shows only what both of them have.
Side by side
Compare
Put up to 4 companies, funds, commodities or coins next to each other — health, valuation, growth and performance.
Every row is computed the same way for every column, from each company's own annual filing, so a comparison is not a collection of whichever figures each of them chose to put in a press release. Funds are compared on what a fund is actually judged on: cost, income, spread and record.
Relative performance
Rebased so every symbol starts at 0%
Loading price history…
Side by side
Latest annual figures from each company's filings
| Metric | ALBALBEMARLE CORP | ECLECOLAB INC. | PPGPPG INDUSTRIES INC | IFFINTERNATIONAL FLAVORS & FRAGRANCES INC | Median of the restexcluding ALB |
|---|---|---|---|---|---|
| Type | Company | Company | Company | Company | |
| Price | $92.54▼ 1.93 (2.04%) | $292.30▲ 4.21 (1.46%) | $113.09▲ 2.92 (2.65%) | $91.03▼ 0.18 (0.20%) | |
| Health scoreComposite of profitability, growth, debt and accounting quality. | 4.0/10 | 9.0/10 | 8.0/10 | 4.0/10 | 8.0/10 |
| Market value | $10.89B | $82.43B | $25.27B | $23.28B | |
| Revenue | $5.14B | $16.08B | $15.88B | $10.89B | |
| Profit | -$510.6M | $2.08B | $1.58B | -$359.0M | |
| Revenue growthChange in sales versus the prior year. | -4.4% | 2.2% | 0.2% | -5.2% | 0.2% |
| Gross marginShare of sales left after the direct cost of producing them. | 13.0% | 44.5% | 41.3% | 36.2% | 41.3% |
| Operating marginShare of sales left after running the business, before interest and tax. | -7.1% | 17.0% | — | -3.5% | 6.8% |
| Profit marginProfit kept from each dollar of sales. | -9.9% | 12.9% | 9.9% | -3.3% | 9.9% |
| Free cash flow marginCash left after capital spending, as a share of sales. | 13.5% | 11.8% | 7.3% | 2.4% | 7.3% |
| Return on equityProfit against the owners' stake in the company. | -5.4% | 21.2% | 19.8% | -2.5% | 19.8% |
| Return on invested capital (approx.)Operating profit after tax against equity plus debt, less cash. Cash here excludes short-term investments, so this runs low for cash-rich companies. | -2.6% | 12.8% | — | -1.5% | 5.7% |
| P/E ratioPrice paid per dollar of annual profit. | — | 39.71x | 16.03x | — | 27.87x |
| EV / EBITDA (approx.)Market value plus debt less cash, against operating profit before depreciation. Cash excludes short-term investments, so this runs high for cash-rich companies. | 42.76x | 26.40x | — | 49.45x | 37.92x |
| Price to book | 1.14x | 8.44x | 3.18x | 1.64x | 3.18x |
| Debt to equityTotal liabilities compared with owners' stake. | 0.72x | 1.52x | 1.76x | 0.80x | 1.52x |
| Piotroski F-ScoreNine checks of financial strength. Higher is stronger. | 6/9 | 6/9 | 6/9 | 6/9 | 6.0 |
| Bankruptcy riskAltman Z-Score zone. | distress | safe | safe | distress |
How ALB compares with the others
- ALB's operating margin of -7.1% is lower than the median of the other companies selected (6.8%).
- Its revenue grew more slowly than the median of the other companies selected: -4.4% against 0.2%.
- It has no P/E to set against theirs, because it did not make a profit.
- Its liabilities are lower relative to equity than the median of the other companies selected: 0.7x against 1.5x.
Measured against the other companies entered, from each one's latest annual filing. A difference describes the companies; it does not rank them.